• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

The Invus Group

edit

The Invus Group, LLC is a private equity and venture capital firm specializing in buyouts, buyins, Turnaround, public equity investments, early stage, and expansion capital investments. The firm seeks to invest in the Technology sector including telecommunications, Information technology, Biotechnology/ Medical, industry sector including Industrial goods and services, other manufactured goods, Consumer goods, and food industry sector. The firm prefers to invest in Europe with a focus on France and North America. It makes equity investments in both private and public companies. The firm prefers to invest the maximum of Ђ500 Million ($742.22 Million) in its portfolio companies. It invests in private companies where it can take majority control positions. But it also makes minority investments in high-growth companies. The firm can also take significant, long-term positions in public companies and focuses on small to mid-cap public stocks. It prefers to be a lead investor and often makes 100 percent equity investments in its portfolio companies. The firm does not work on club deals and participates with owner managers. The Invus Group, LLC was founded in 1985 and is based at New York, New York with additional offices at London, United Kingdom and Paris, France.

Recent Milestones

edit

• 
  The Invus Group invested in Lexicon Pharmaceuticals. (3/15/10)
  Posted 7/20/10 at 5:21pm via thefreelibrary.com
• 
  The Invus Group invested in Netcontinuum. (10/17/05)
  Posted 8/5/10 at 6:35pm via prnewswire.com
• 
  The Invus Group invested in Elixir Medical. (3/18/05)
  Posted 5/28/10 at 6:39am via sec.gov

Investments

Videos

Sources

1. United States : Invus-Backed Lexicon Pharmaceuticals Closes on $75M - cbl. (thefreelibrary.com) [edit]
2. NetContinuum Secures $15M in Financing and Appoints Former Extreme Networks Executive as CEO (www2.prnewswire.com) [edit]
3. sec.gov [edit]